
According to reports from Business Standard, MKVentures Capital experienced a significant decline in profitability during the December 2025 quarter. The company's consolidated net profit fell 56.77% to ₹2.33 crore in Q3 FY2026, compared to ₹5.39 crore in the corresponding quarter of the previous year. This substantial decline reflects challenging market conditions or operational factors that impacted the company's bottom line performance. The sequential decline was equally troubling, with profits dropping 33.62% from Q2 FY26's ₹3.51 crores, indicating continued pressure on the company's financial performance.
As reported by Business Standard, the company's sales declined 64.30% to ₹1.76 crore in the quarter ended December 2025, down from ₹4.93 crore in the same period of the previous year. However, the latest data reveals an even more severe revenue contraction, with net sales crashing 54.71% year-on-year to ₹3.56 crores in Q3 FY26 from ₹7.86 crores in the corresponding quarter last year. This dramatic revenue collapse represents the sharpest quarterly decline yet, falling below even the ₹2.88 crores reported in Q4 FY25. On a sequential basis, sales fell 41.35% from Q2 FY26's ₹6.07 crores, with the sequential contraction of 41.35% from Q2 FY26 further underscoring the severity of the revenue challenge.
According to the financial data reported by Business Standard, the company's operating profit margin (OPM) stood at 138.64% in Q3 FY2026, compared to 149.49% in the corresponding quarter of the previous year. The profit before depreciation and tax (PBDT) declined 67% to ₹2.41 crore from ₹7.28 crore year-on-year. Additionally, profit before tax (PBT) also fell 67% to ₹2.35 crore compared to ₹7.18 crore in Q3 FY2025. The operating profit before depreciation, interest, and tax (excluding other income) declined to ₹2.44 crores in Q3 FY26, down from ₹7.37 crores in Q3 FY25, though the operating margin expanded to 138.64% from 149.49%. Interest costs decreased to ₹0.27 crores from ₹0.83 crores year-on-year, providing some relief to the bottom line.
The company's stock performance reflects the underlying business challenges, with MKVentures Capital's stock price declining 37.49% over the past year, significantly underperforming the Sensex's 8.73% gain during the same period. The stock trades at ₹970.00 with a market capitalisation of ₹363.00 crores, down 48.68% from its 52-week high of ₹1,890.05 but still 9.73% above its 52-week low of ₹884.00. The technical picture reinforces the bearish fundamental outlook, with the stock trading below all major moving averages and exhibiting a high beta of 1.50, amplifying both gains and losses. The company's valuation metrics appear stretched relative to its operational performance, trading at a price-to-earnings ratio of 47.50x, significantly higher than the industry average of 23x and substantially above most direct peers. The price-to-book ratio of 3.39x also commands a premium, particularly concerning given the declining ROE trend.
Examining the balance sheet as of March 2025, shareholder funds stood at ₹102.89 crores, comprising ₹3.84 crores in share capital and ₹99.05 crores in reserves. The company maintains a debt-free status with zero long-term debt, which provides financial flexibility but raises questions about growth capital deployment. A notable development is the dramatic surge in investments to ₹73.02 crores in FY25 from just ₹12.19 crores in FY24, representing a nearly six-fold increase in investment holdings. This represents a nearly six-fold increase in investment holdings, raising questions about the company's strategic direction and whether these investments are generating adequate returns. The return on equity (ROE) has deteriorated to 7.13% in the latest period from an average of 13.46%, indicating declining capital efficiency. The shareholding structure has remained remarkably stable over the past five quarters, with promoter holding at 74.36% and complete absence of mutual fund and insurance company participation, signaling limited institutional confidence in the company's prospects.